Domínguez CG, Borunda ND, Takao KF

Idioma: Español
Referencias bibliográficas: 69
Paginas: 191-198
Archivo PDF: 84.01 Kb.

RESUMEN

El virus de la inmunodeficiencia humana (VIH) se ha diseminado a todas las naciones infectando a más de 2.5 millones de personas en todo el mundo. En México se han reportado 71,526 casos de SIDA y se ha estimado que alrededor de 116,000 a 177,000 personas están infectados por el VIH en el grupo de edad entre 15-49 años. En este grupo ocupa la 4ª causa de mortalidad. Aproximadamente 4-5% de los pacientes con VIH son admitidos a la unidad de cuidados intensivos. Implementando diagnósticos adecuados, así como estrategias terapéuticas y profilácticas estos pacientes pueden sobrevivir más. Sin duda alguna, los médicos intensivistas tienen un importante papel estableciendo las medidas de apoyo a los pacientes con VIH para sobrevivir a la crisis aguda, permitiendo así continuar con su vida productiva activa.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Centro Nacional para la prevención y control de VIH/SIDA de la Secretaría de Salud, México. Epidemiología del VIH/SIDA en México en el año 2003. www.salud.gob.mx

2. Dirección General de Epidemiología. Registro Nacional de Casos de SIDA. Secretaría de Salud de México. Datos al 1º de noviembre del 2003. www.epi.org.mx

3. Domínguez-Cherit G, Borunda D, Sierra J. HIV infection in critical care. Gullo A editor, Anaesthesia, Pain, Intensive Care and Emergency Medicine. 1a ed. Milano, Italia: Springer-Verlag, 2003:165-96.

4. Niu MT, Stein DS, Schnittman. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in human and animal retrovirus infections. J Infect Dis 1993;(168):1490.

5. Pedersen C, Lindhardt BO, Jensen BL et al. Clinical course of primary HIV infection consequences for subsequent course infection. BMJ (299):154.

6. 6 Horsburgh CR Jr, Ou CY, Jason J et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;(II):637.

7. Centers for Disease Control and Prevention. Surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36:15.

8. Centers for Disease Control and Prevention. Surveillance for AIDS: defining opportunistic illness 1992-1997. MMWR Morb Mortal Wkly Rep 1999;48:1.

9. Sande ME, Gilbert DN, Moellering RC, editors. Guía Sanford de tratamiento VIH/SIDA. 8ª ed. México, D.F; Intersistemas; 2000.

10. Dybul M, Fauci As, Bartlett JG et al. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep 2002;17;51(RR-7):1-55.

11. Mellors JW, Munoz A, Giofgi JV et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;(126):946.

12. Vlahov D, Graham N, Hoover D et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users. Plasma viral load and CD4+ cell count. JAMA 1998;(279):35.

13. Glassock RJ, Cohen AH, Danovitch G, Parsa KP. Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med 1990;(112):35.

14. Vitting KE, Gardenswartz MH, Zabetakis PM et al. Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immune deficiency syndrome. JAMA 1990;(263):973.

15. Tang WW, Kaptein EM, Feinstein El, Massry SG. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med 1993;(94):169.

16. Freda PU, Wardlaw SL, Brudney K, Goland RS. Clinical case seminar. Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome. A report of five cases. J Clin Endocrinol Metab 1994;(79):1540.

17. Glasgow BJ, Steinsapir KD, Anders K, Layfield LJ. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Pathol 1985;(84):594.

18. Kalin MF, Poretsky L, Seres DS, Zumoff B. Hyporeninemic hypoaldosteronism associated with AIDS. Am J Med 1987;(82):1035.

19. Guy RJ, Turberg Y, Davidson RN et al. Mineralocorticoid deficiency in HIV infection. BMJ 1989;(298):496.

20. Choi MJ, Fernandez PC, Patnaik A et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 1993;(328):703.

21. Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 1993;(119):291.

22. Velazquez H, Perazella M, Wright FS, Ellison DH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 1993;(119):296.

23. Chattha G, Arieff Al, Cummings C, Tierney LM Jr. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993;(118):37.

24. Sundar K, Suarez M, Banogon PE, Shapiro JM. Zidovudine-induced fatallactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. Crit Care Med 1997;(25):1425.

25. Lenzo NP, Garas BA, French MA. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS 1997;(11):1294.

26. Gopinath R, Hutcheon M, Cheema-Dhadli S, Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephro 1992;(13):1212.

27. Gallant J, Moore R, Richman D et al. Incidence and natural history of cytomegalovirus disease in patients with advanced bullan immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;(166):1223.

28. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996;(125):577.

29. Revello MG, Percivalle E, Sarasini et al. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 1994;(170):1275.

30. Arribas JR, Clifford DB, Fichtenbaum CJ et al. Level of cytomegalovirus (CMV) DNAin cerebrospinal fluid of subjects with AIDS and CMV infection of central nervous system. J Infect Dis 1995;(172):527.

31. Flood J, Drew WL, Miner R et al. Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis 1997;(176):348.

32. Small PM, McPhaulLW, Sooy CD et al. Cytomegalovirus infection of the laryngeal nerve presenting as hoarseness in patients with acquired immunodeficiency syndrome. Am J Med 1989;(86):108.

33. Whitley RJ, Jacobson MA, Friedberg DN et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. Arch Intern Med 1998;(158):957.

34. Kales CP, Murren JR, Torres RA, Crocco JA. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. Arch Intern Med 1987;(147):1413.

35. De Lorenzo LJ, Huang CT, Maguire GP, Stover DE. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987;(91):323.

36. Jules-Elysee K, Stover DE, Zaman MB et al. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990;(112):750.

37. Huang L, Stansell J, Osmond D et al. Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Chest 1999;(115):1025.

38. Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia: diagnostic and prognostic significance. Am Rev Respir Dis 1988;(137):796.

39. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis of Pneumocystis carinii pneumonia in AIDS. JAMA 1988;(259): 1185.

40. Noskin GA, Murphy RL, Black JR, Phair FP. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin Infect Dis 1992;(14):183.

41. Leoung GS, Mills J, Hopewell VC et al. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1994;(121): 174.

42. Hughes WT, Leoung G, Kramer F et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993;(328):1521.

43. Smith D, Davies S, Smithson J et al. Elfomithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients. AIDS 1992;(6):1489.

44. Montaner JSG, Lawson LM, Levitt N et al. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;(113):14.

45. Gagnon S, Boota AM, Fischl MA et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;(323):1444.

46. Bozzette SA, Sattler Fr, Chin J et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;(323):1451.

47. Curtis JR, Yarnold PR, Schwartz DN et al. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2000;(162):393.

48. Helweg-Larsen J, Benfield TL, Eugen-Olsen J et al. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999;(354):1347.

49. Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993;(138):909.

50. Hirschtick R, Glassroth J, Jordan M et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;(333):845.

51. Polsky B, Gold JWM, Whimbey E et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;(104):38.

52. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987;(82):900.

53. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 1993;(148):992.

54. Murray JF, Felton CP, Garay SM et al. Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 1984;(310):1682.

55. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia: mortality in acquired immunodeficiency syndrome. Chest 1992;(101):150.

56. Monkemuller KE, Call SA, Lazenby AJ, Wilcox CM. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000;(95):457.

57. Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000;(95):3482.

58. Chioralia G, Trammer T, Kampen H, Seitz HM. Relevant criteria for detecting microsporidia in stool specimens. J Clin Microbiol 1998;(36):2279.

59. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991;(4):S-29.

60. Parente F, Cernuschi M, Antinori S et al. Severe abdominal pain in patients with AIDS: frequency, clinical aspects, causes and outcome. Scand J Gastroenterol 1994;(29):511.

61. Ferguson CM. Surgical complications of human immunodeficiency virus infection. Am Surg 1988;(54):4.

62. Wood BJ, Kumar PN, Cooper C et al. AIDS-associated intussusception in young adults. J Clin Gastroenterol 1995;(21):158.

63. Dassopoulos T, Ehrenpreis ED. Acute pancreatitis in human immunodeficiency virus infected patients: a review. Am J Med 1999;(107):78.

64. Bonacini M. Pancreatic involvement in bullan immunodeficiency virus infection. J Clin Gastroenterol 1991;(13):58.

65. Floridia M, Vella S, Seeber AC et al. A randomized trial (lSS 902) of didanosine versus zidovudlne in previously untreated patients with mildly symptomatic human immunodeficiency virus infection. J Infect Dis 1997;(175):255.

66. Jeffrey RB. Gastrointestinal imaging in AIDS - abdominal computed tomography and ultrasound. Gastroenterol Clin North Am 1988;(17):507.

67. Cappell MS, Shetty V. A multicenter, case-controlled study of the clinical presentation and etiology of as cites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients. Am J Gastroenterol 1994;(89):2172.

68. Wilcox CM, Forsmark CE, Grendell JH et al. Cytomegalovirus-associated acute pancreatic disease in patients with acquired immunodeficiency syndrome. Gastroenterology 1991;(99):263.

69. Glasgow BJ, Anders K, Layfield LJ. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol 1985;(83):582.